CUE icon

Cue Biopharma

45 hedge funds and large institutions have $51.3M invested in Cue Biopharma in 2019 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 21 increasing their positions, 6 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
45
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$7.5M
2 +$2.53M
3 +$1.21M
4
BlackRock
BlackRock
New York
+$617K
5
HSBC Holdings
HSBC Holdings
United Kingdom
+$574K

Top Sellers

1 -$221K
2 -$119K
3 -$64.3K
4
RCG
Rock Creek Group
District of Columbia
-$60.6K
5
Citigroup
Citigroup
New York
-$21.7K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$11.6M
2
$10.3M
3
$7.5M
4
$6.37M
5
$2.53M
6
$2.41M
7
$1.89M
8
$1.78M
9
$590K
10
$574K
11
$508K
12
$473K
13
$471K
14
$422K
15
$411K
16
$409K
17
$358K
18
$258K
19
$240K
20
$237K
21
$227K
22
$224K
23
$199K
24
$129K
25
$121K